Skip to main content

Regeneron Pharmaceuticals



) pushed the Health Care sector lower today making it today's featured Health Care loser. The sector as a whole closed the day up 1.3%. By the end of trading, Regeneron Pharmaceuticals fell $2.39 (-2.1%) to $113.70 on light volume. Throughout the day, 549,112 shares of Regeneron Pharmaceuticals exchanged hands as compared to its average daily volume of one million shares. The stock ranged in price between $112.57-$116.52 after having opened the day at $114.93 as compared to the previous trading day's close of $116.09. Other company's within the Health Care sector that declined today were:

Omeros Corporation



), down 20%,

Osiris Therapeutics



), down 17.4%,

Dynacq Healthcare



), down 12%, and

TheStreet Recommends




), down 11.9%.

  • ACTIVE STOCK TRADERS: Check out TheStreet's special offer for Real Money, headlined by Jim Cramer, now!

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines for the treatment of serious medical conditions in the United States. Regeneron Pharmaceuticals has a market cap of $10.6 billion and is part of the


industry. Shares are up 109.4% year to date as of the close of trading on Tuesday. Currently there are nine analysts that rate Regeneron Pharmaceuticals a buy, no analysts rate it a sell, and five rate it a hold.

TheStreet Ratings rates Regeneron Pharmaceuticals as a


. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity, weak operating cash flow and poor profit margins.

On the positive front,

Aoxing Pharmaceutical Company



), up 34.9%,

Arena Pharmaceuticals



), up 28.7%,

Lincare Holdings



), up 23.4%, and




), up 21.5%, were all gainers within the health care sector with

Baxter International



) being today's featured health care sector winner.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider

Health Care Select Sector SPDR



) while those bearish on the health care sector could consider

ProShares Ultra Short Health Care